FORENSIC PSYCHIATRY RESEARCH IN THE SETTING OF THE JUSTICE SYSTEM
With
Professor Kimberlie Dean, Head of Discipline
UNSW Psychiatry and Mental Health
Faculty of Medicine and Health, UNSW & Clinical Academic Forensic Psychiatrist
and Research Lead for Forensic Mental Health Justice Health and Forensic Mental Health Network, Sydney, Australia
RESEARCHER PROFILE
Filmed in Sydney, Australia | May 2025
Prof Kimberlie Dean is Head of the Discipline of Psychiatry and Mental Health at UNSW. She was appointed to the inaugural Chair in Forensic Mental Health at UNSW in 2011, a joint appointment with Justice Health NSW. She also holds a Clinical Academic appointment as a Consultant Forensic Psychiatrist with Justice Health NSW. She is Academic Program Director for the Masters Forensic Mental Health at UNSW.
Her academic journey commenced with studying medicine at the University of Tasmania and the University of Adelaide. During her medical training, she became intrigued by broader questions concerning mental health, which sparked her interest in epidemiological and population health research.
Prof Dean trained at the Institute of Psychiatry and Maudsley Hospital in London, completing clinical training in Forensic Psychiatry and a PhD in Epidemiological Psychiatry. She returned to Australia over ten years ago to continue her work at UNSW.
Her research interests include understanding links between mental illness and offending behaviour including violence and testing interventions in justice settings/populations. She is currently involved in a range of research projects involving survey methodology, data linkage and intervention evaluation.
At the heart of her research is a commitment to uncovering the truth and enhancing mental health for the most vulnerable community members.
Source: Supplied and adapted
You Might also like
-
Genetic disease research imitating function and architecture of organs
Professor Wolvetang was among the first to bring the first human embryonic stem cells to Queensland, with his Wolvetang Group at the AIBN now renowned for its work with organoids: growing them, studying them, and using them to try and understand diseases and human development.
Using cutting edge technology, Professor Wolvetang designs and grows organoids both for their own work and for labs across the country, coaxing pluripotent stem cells or tissue samples into 3D structures that mimic the function and architecture of real brains, livers, kidneys, spinal cords, and intestines.
-
Dr James Pang
DR JAMES PANG, RESEARCH FELLOW
TURNER INSTITUTE FOR BRAIN AND MENTAL HEALTH, MONASH UNIVERSITY
VICTORIA, AUSTRALIA -
World-first clinical trial improves patient outcomes for kidney transplants (2023)
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Around one in three people who receive a kidney transplant suffer delayed graft function, which means the transplant doesn’t work immediately and they require dialysis.
The lead-author of the study, was Royal Adelaide Hospital Nephrologist and University of Adelaide researcher, Dr Michael Collins.